THURSDAY, April 18, 2024 (HealthDay News) — Deep-seated racial and ethnic disparities persist in health care across the United States, even in states considered the most progressive, a new report shows. For example, California received a score of 45 for the care its health system provides Hispanic Americans. The CommonwealthContinue Reading
WEDNESDAY, April 17, 2024 (HealthDay News) — Two implanted heart devices used by patients in end-stage heart failure are now under a strict U.S. Food and Drug Administration recall, after being tied to 273 known injuries and 14 deaths, the agency said Tuesday. The HeartMate II and HeartMate 3 areContinue Reading
FRIDAY, April 12, 2024 (HealthDay News) — Nearly a quarter of Americans who lost their pandemic-era Medicaid coverage say they’re now without any health insurance, a new survey finds. More than half (54%) of these currently uninsured adults cited cost as the reason keeping them from having coverage. The surveyContinue Reading
THURSDAY, April 11, 2024 (HealthDay News) — Black women with cancer in one breast are less likely than white women to have the healthy breast removed as well, a new study has found. Women with cancer affecting one breast often elect to have the other breast removed, for a varietyContinue Reading
WEDNESDAY, April 10, 2024 (HealthDay News) — More middle-aged Black and Native Americans are now falling prey to “deaths of despair” than whites, a new study finds. These deaths — from suicide, drug overdose and alcoholic liver disease — initially had been more common among whites. But a new analysisContinue Reading
WEDNESDAY, April 10, 2024 (HealthDay News) — Phillips Respironics, the company responsible for the recall of millions of defective sleep apnea machines since 2021, must overhaul its production of the machines before it can resume making them in the United States, federal officials announced Tuesday. Under a settlement reached withContinue Reading
MONDAY, April 8, 2024 (HealthDay News) — New research questions the effectiveness of the U.S. Food and Drug Administration’s accelerated drug approval program after finding that many cancer drugs remain unproven five years later. The study, published Sunday in the Journal of the American Medical Association and presented simultaneously atContinue Reading
FRIDAY, April 5, 2024 (HealthDay News) — A test to gauge if it’s safe to prescribe a patient an addictive opioid may have been approved too soon by the U.S. Food and Drug Administration, claims a letter sent to the agency by a group of experts. The test, called AvertD,Continue Reading
THURSDAY, April 4, 2024 (HealthDayNews) — Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, and the drug “will noContinue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — A Texas plant full of egg-laying hens has been shut down temporarily after bird flu was detected in the animals. Cal-Maine Foods, the largest egg producer in the country, said in a news release issued Tuesday that it had to subsequently cull about 1.6Continue Reading